GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lupin Ltd (NSE:LUPIN) » Definitions » Other Long-Term Liabilities

Lupin (NSE:LUPIN) Other Long-Term Liabilities : ₹9,670 Mil (As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Lupin Other Long-Term Liabilities?

Lupin's other long-term liabilities for the quarter that ended in Mar. 2024 was ₹9,670 Mil.

Lupin's quarterly other long-term liabilities declined from Sep. 2023 (₹10,616 Mil) to Dec. 2023 (₹0 Mil) but then increased from Dec. 2023 (₹0 Mil) to Mar. 2024 (₹9,670 Mil).

Lupin's annual other long-term liabilities declined from Mar. 2022 (₹6,260 Mil) to Mar. 2023 (₹5,908 Mil) but then increased from Mar. 2023 (₹5,908 Mil) to Mar. 2024 (₹9,670 Mil).

Lupin Other Long-Term Liabilities Historical Data

The historical data trend for Lupin's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lupin Other Long-Term Liabilities Chart

Lupin Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Lupin Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Lupin Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Lupin Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Lupin's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Lupin (NSE:LUPIN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lupin Ltd (NSE:LUPIN) » Definitions » Other Long-Term Liabilities
Comparable Companies
NSE:AUROPHARMA BOM:532321 NSE:ALKEM NSE:TORNTPHARM BOM:543904 BOM:524494 BOM:532331 BOM:506943 BOM:532296 BOM:540222 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
500257:India
Address
Off. Western Express Highway, 3rd floor, Kalpataru Inspire, Santacruz (East), Mumbai, MH, IND, 400 055
Website
https://www.lupin.com
Lupin Ltd is a specialty and generic drug manufacturing company. The company's global formulations business develops and delivers a wide range of branded and generic formulations across the globe. The operations of the company are limited to one segment, namely pharmaceuticals and related products. The company also maintains a pipeline in high-barrier markets such as Inhalation, Biosimilars and Complex Injectables. The vast majority of the company's sales are generated in the United States, followed by India.

Lupin (NSE:LUPIN) Headlines

No Headlines